<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03457831</url>
  </required_header>
  <id_info>
    <org_study_id>ICTAL SE REGISTRY</org_study_id>
    <nct_id>NCT03457831</nct_id>
  </id_info>
  <brief_title>Status Epilepticus in the Critically Ill Patients</brief_title>
  <official_title>Status Epilepticus in the Critically Ill Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ictal Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Versailles Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ictal Group</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Convulsive and Non Convulsive Status Epilepticus (SE) and Pseudo Status Epilepticus
      prospective registry.

      Data collection using a standardized form : demographic data and data related to the SE,
      including circumstances of onset, dates and times of onset and of seizure control, on-scene
      clinical findings, clinical features of the seizures, pre-hospital and hospital care
      providers, timing of antiepileptic and supportive treatments, results of etiological
      investigations, cause of SE, type and dosage of antiepileptic drugs. Dates and times of EEG
      monitoring, EEG results. Outcomes including vital status and Glasgow Outcome Scale score at
      ICU and hospital discharge, day-90 and 1-year after SE and determined based on data in the
      ICU and/or neurologist charts and/or patients phone interview.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 28, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2028</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2028</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Favorable outcome</measure>
    <time_frame>1 year</time_frame>
    <description>A favorable outcome is defined by a Glasgow Outcome Scale (GOS) of 5. The Glasgow Outcome Scale (GOS) will be determined according to patients charts review and/or general practitioner interview conducted by an independent assessor. The GOS score : [1: Death, 2: Persistent vegetative state, 3: Severe disability, 4: Moderate disability, 5 : Low disability]</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Favorable outcome</measure>
    <time_frame>3 months, 5-years and 10 years</time_frame>
    <description>A favorable outcome is defined by a Glasgow Outcome Scale (GOS) of 5. The Glasgow Outcome Scale (GOS) will be determined patients charts review and/or general practitioner interview conducted by an independent assessor. The GOS score : [1: Death, 2: Persistent vegetative state, 3: Severe disability, 4: Moderate disability, 5 : Low disability]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional impairment</measure>
    <time_frame>3 months, and 1-year, 5-years and 10-years</time_frame>
    <description>Percentages of the patients that experience functional impairment (motor, sensitive, cognitive, epilepsy)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>total seizure duration</measure>
    <time_frame>72 hours</time_frame>
    <description>total seizure duration in minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>percentages of the patients that experience recurrent convulsive and/or non-convulsive seizures within 12 hours after ICU admission</measure>
    <time_frame>12 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>refractory status epilepticus</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>super refractory status epilepticus</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>total ICU and in-hospital length of stay</measure>
    <time_frame>90 days</time_frame>
    <description>total ICU and in-hospital length of stay in days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mortality rate</measure>
    <time_frame>ICU and hospital discharge, 3-months, and 1-year, 5 years and 10 years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Status Epilepticus</condition>
  <arm_group>
    <arm_group_label>Status Epilepticus</arm_group_label>
    <description>Convulsive and Non-Convulsive Status Epilepticus ; and Pseudo Status Epilepticus</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        critically ill patients requiring ICU hospitalisation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  SE defined as 5 min or more of (i) continuous clinical and/or electrographic seizure
             activity or (ii) recurrent seizure activity without recovery (returning to baseline)
             between seizures.

          -  age &gt;= 18 years

        Exclusion Criteria:

          -  age &lt; 18 years

          -  postanoxic status epilepticus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>stephane LEGRIEL, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ictal Group</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>stephane LEGRIEL, MD</last_name>
    <phone>+33139639717</phone>
    <email>slegriel@ch-versailles.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Liège</name>
      <address>
        <city>Liège</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dider Ledoux, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Hayet Hammar</last_name>
    </contact_backup>
    <investigator>
      <last_name>Didier LEDOUX, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Benoit MISSET, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Angouleme - Service de réanimation polyvalente</name>
      <address>
        <city>Angoulême</city>
        <zip>16959</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David SCHNELL, MD</last_name>
      <phone>+33 5 45 24 41 57</phone>
      <email>david.schnell@ch-angouleme.fr</email>
    </contact>
    <investigator>
      <last_name>David SCHNELL, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Beauvais - Service de réanimation polyvalente</name>
      <address>
        <city>Beauvais</city>
        <zip>60000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jack RICHECOEUR, MD</last_name>
      <phone>+ 33 3 44 11 21 87</phone>
      <email>jack.richecoeur@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Jack RICHECOEUR, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Bethune - Service de Réanimation et Surveillance continue</name>
      <address>
        <city>Beuvry</city>
        <zip>62660</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caroline SEJOURNE, MD</last_name>
      <phone>+33 0321 644 482</phone>
      <email>csejourne@ch-bethune.fr</email>
    </contact>
    <contact_backup>
      <last_name>Christophe VINSONNEAU</last_name>
      <phone>+33 0321 644 482</phone>
      <email>cvinsonneau@ch-bethune.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Régional</name>
      <address>
        <city>Brest</city>
        <zip>29200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre BAILLY, MD</last_name>
      <email>pierre.bailly@chu-brest.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH Brive La Gaillarde - Service de réanimation - USC</name>
      <address>
        <city>Brive-la-Gaillarde</city>
        <zip>19100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas PICHON, MD</last_name>
      <phone>+33 5 55 92 60 13</phone>
      <email>nicolas.pichon@ch-brive.fr</email>
    </contact>
    <investigator>
      <last_name>Nicolas PICHON, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Public du Cotentin - Service de Réanimation - Médecin intensive</name>
      <address>
        <city>Cherbourg</city>
        <zip>50102</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bertrand SAUNEUF, MD</last_name>
      <phone>+ 33 2 33 20 76 80</phone>
      <email>b.sauneuf@ch-cotentin.fr</email>
    </contact>
    <investigator>
      <last_name>Bertrand SAUNEUF, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Beaujon</name>
      <address>
        <city>Clichy</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mathilde HOLLEVILLE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Mathilde HOLLEVILLE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopitaux Universitaires Henri Mondor - Service d'anesthésie et des réanimations chirurgicales, Unité d'anesthésie-réanimation chirurgical cardiovasculaire</name>
      <address>
        <city>Créteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas MONGARDON, MD, PhD</last_name>
      <phone>+ 33 1 49 81 21 11</phone>
      <email>nicolas.mongardon@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Nicolas MONGARDON, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Dieppe</name>
      <address>
        <city>Dieppe</city>
        <zip>76202</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Philippe RIGAUD, MD, PhD</last_name>
      <phone>+ 33 2 32 14 75 49</phone>
      <email>JRigaud@ch-dieppe.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Philippe RIGAUD, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Audrey MASSARD</last_name>
      <phone>+33 3 80 28 13 03</phone>
      <email>audrey.massard@chu-dijon.fr</email>
    </contact>
    <contact_backup>
      <last_name>Solenne VILLOT</last_name>
      <phone>+33 3 80 28 13 03</phone>
      <email>solenne.villot@chu-dijon.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Jean-Pierre QUENOT, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de La Rochelle - Service de réanimation - USC</name>
      <address>
        <city>La Rochelle</city>
        <zip>17019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier LESIEUR, MD, PhD</last_name>
      <phone>+ 33 5 46 45 66 54</phone>
      <email>olivier.lesieur@ch-larochelle.fr</email>
    </contact>
    <investigator>
      <last_name>Olivier LESIEUR, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Intensive Care Unit - Versailles Hospital</name>
      <address>
        <city>Le Chesnay</city>
        <zip>78150</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>stephane LEGRIEL, MD</last_name>
      <email>slegriel@ch-versailles.fr</email>
    </contact>
    <investigator>
      <last_name>Stephane LEGRIEL, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gwenaëlle JACQ, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital privé Jacques Cartier - Service de réanimation médico chirurgicale</name>
      <address>
        <city>Massy</city>
        <zip>91300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wulfran BOUGOUIN, MD, PhD</last_name>
      <phone>+ 33 1 60 13 60 60</phone>
      <email>wulfran.bougouin@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Wulfran BOUGOUIN, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier Sud Ile de France - Service de Réanimation - Médecin intensive</name>
      <address>
        <city>Melun</city>
        <zip>77011</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonathan CHELLY, MD</last_name>
      <phone>+ 33 1 64 71 66 21</phone>
      <email>jonathan.chelly@ch-melun.fr</email>
    </contact>
    <contact_backup>
      <last_name>Nathalie ROLLIN, MD</last_name>
      <email>nathalie.rolin@ch-melun.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Jonathan CHELLY, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nathalie ROLLIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Baptiste LASCARROU, MD</last_name>
      <phone>02 53 48 24 73</phone>
      <email>jeanbaptiste.lascarrou@chu-nantes.fr</email>
    </contact>
    <contact_backup>
      <last_name>Diane MAUGARS</last_name>
      <email>Diane.MAUGARS@chu-nantes.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Jean-Baptiste LASCARROU, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier Paris Saint Joseph - Service de réanimation médico chirurgicale</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cedric BRUEL, MD</last_name>
      <phone>+ 33 1 44 12 30 85</phone>
      <email>cbruel@hpsj.fr</email>
    </contact>
    <investigator>
      <last_name>Cedric BRUEL, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HP Claude Galien - Service de Réanimation Polyvalente</name>
      <address>
        <city>Quincy-sous-Sénart</city>
        <zip>91480</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arnaud GALBOIS, MD, PhD</last_name>
      <phone>+33 1 69 39 90 00</phone>
      <email>galbois@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Arnaud GALBOIS, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier de Roanne - Service de Réanimation - Soins continus</name>
      <address>
        <city>Roanne</city>
        <zip>42328</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pascal BEURET, MD</last_name>
      <phone>+33 4 77 44 31 07</phone>
      <email>pascal.beuret@ch-roanne.fr</email>
    </contact>
    <investigator>
      <last_name>Pascal BEURET, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Toulon</name>
      <address>
        <city>Toulon</city>
        <zip>83100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonathan CHELLY, MD</last_name>
      <phone>04 94 14 50 00</phone>
      <email>JONATHAN.CHELLY@ch-toulon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>February 28, 2018</study_first_submitted>
  <study_first_submitted_qc>March 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 8, 2018</study_first_posted>
  <last_update_submitted>January 23, 2020</last_update_submitted>
  <last_update_submitted_qc>January 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Status Epilepticus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

